Bio, work history, education & how to reach out.
Founder at NewLimit
*******@newlimit.com
+1 **********
Last updated: 2026-03-03
Blake Byers is a biotech and tech investor and entrepreneur, co-founder of NewLimit, and founder of Byers Capital. He has a background in bioengineering and biomedical engineering from Stanford and Duke University, respectively. Blake has a history of investing in and building innovative companies across technology and healthcare sectors.
Blake Byers has extensive experience as a venture investor and entrepreneur, having served as a General Partner at GV for over a decade, leading investments in numerous successful startups. He co-founded NewLimit in 2022 to develop therapies aimed at extending human healthspan and longevity.
Blake holds a PhD and MS in Bioengineering from Stanford University and dual BS degrees in Biomedical Engineering and Economics from Duke University.
NewLimit is a biotechnology company focused on developing epigenetic reprogramming therapies to extend human healthspan. The company leverages genomics, machine learning, and high-throughput assays to discover rejuvenating interventions and aims to restore youthful function to aged cells.
NewLimit raised a $130 million Series B led by Kleiner Perkins, with additional investments from Nat Friedman, Daniel Gross, Khosla Ventures, Founders Fund, Dimension Capital, and others.
You can reach Blake Byers at *******@newlimit.com or by calling +1 **********. To get Blake Byers's contact information and other startup founders like this, sign up for a free account at Anybody.com.
Get thousands of B2B leads like this for free, no credit card required.
Get started for free